help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lan, N. C.
Right arrow Articles by Baxter, J. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lan, N. C.
Right arrow Articles by Baxter, J. D.

Journal of Clinical Endocrinology & Metabolism, Vol 55, 516-523, Copyright © 1982 by Endocrine Society


ARTICLES

A radioreceptor assay for direct measurement of plasma free glucocorticoid activity

NC Lan and JD Baxter

An assay for plasma free glucocorticoid receptor-binding activity has been developed with the use of specific glucocorticoid receptors in cultured rat pituitary tumor cells (GC line). Unlike other assays for corticosteroids, this assay measures the summed free (rather than the total) receptor-binding activity of all natural and synthetic steroids present in the sample. Plasma samples (0.5 ml) were incubated with [3H]dexamethasone and GC cells at 37 C for 45 min, and the nuclear bound dexamethasone was then measured. The free glucocorticoid receptor- binding activity was determined by the extent to which steroids present in the sample inhibit binding of the 3H-labeled steroids. Free cortisol concentrations of 0.3-3.6 micrograms/dl were accurately detected. That the assay measures free but not total steroids and that the free steroid provides the correct index of receptor-occupying capability were verified by two findings: 1) the assay yields similar results when the free cortisol is separated from plasma and then run in the assay, and 2) the receptor-binding activity of dexamethasone in plasma is reduced to the extent of plasma binding of this steroid measured directly. Free receptor-binding activity of adult plasma taken at various times determined by the assay correlated well with that expected from the total cortisol levels (measured by the corticosteroid- binding globulin-isotope assay) and the extent of plasma binding. The utility of the assay for measuring plasma dexamethasone levels after oral administration of the steroid is shown. The assay should be useful to determine the free glucocorticoid receptor-binding activity in plasma due to cortisol, synthetic glucocorticoids, or unidentified medication. In most circumstances, i.e. when antagonists are not present in sufficient quantities, such activity should equal the free glucocorticoid activity as well.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1982 by The Endocrine Society